Spots Global Cancer Trial Database for Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment
Official Title: Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment
Study ID: NCT04143282
Conditions
Study Description
Brief Summary: This study aims to determine the effect of metformin along with standard cancer treatment, and its effect on the prognosis of the metastatic breast in non-diabetic patients.
Detailed Description: the role of metformin when combined with traditional metastatic breast cancer treatment in non-diabetic patients compared to diabetic patients who are not using metformin. In this randomized control study, there will be a demonstration either it is effective to suppress tumor burden or not through normal screening for tumor.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Beni-Seuf University Hospital, Banī Suwayf, , Egypt
Contact Details
Name: ahmed a berry, PhD
Affiliation: Faculty of Medicine, Beni Suef University
Role: STUDY_DIRECTOR
Name: ahmed h shaaban, MD
Affiliation: Faculty of Medicine, Beni Suef University
Role: STUDY_DIRECTOR
Name: hoda m rabea, PhD
Affiliation: Faculty of pharmacy, Beni Suef University
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
